Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Structural Genomics Unit, Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Molecules. 2024 Mar 6;29(5):1185. doi: 10.3390/molecules29051185.
Sirtuins are NAD-dependent protein deacylases and key metabolic regulators, coupling the cellular energy state with selective lysine deacylation to regulate many downstream cellular processes. Humans encode seven sirtuin isoforms (Sirt1-7) with diverse subcellular localization and deacylase targets. Sirtuins are considered protective anti-aging proteins since increased sirtuin activity is canonically associated with lifespan extension and decreased activity with developing aging-related diseases. However, sirtuins can also assume detrimental cellular roles where increased activity contributes to pathophysiology. Modulation of sirtuin activity by activators and inhibitors thus holds substantial potential for defining the cellular roles of sirtuins in health and disease and developing therapeutics. Instead of being comprehensive, this review discusses the well-characterized sirtuin activators and inhibitors available to date, particularly those with demonstrated selectivity, potency, and cellular activity. This review also provides recommendations regarding the best-in-class sirtuin activators and inhibitors for practical research as sirtuin modulator discovery and refinement evolve.
Sirtuins 是 NAD 依赖性蛋白去酰基酶和关键的代谢调节剂,通过将细胞能量状态与选择性赖氨酸去酰化偶联,来调节许多下游细胞过程。人类编码了 7 种具有不同亚细胞定位和去酰基酶靶标的 Sirtuin 同工型(Sirt1-7)。Sirtuins 被认为是保护性抗衰老蛋白,因为增加 Sirtuin 的活性与延长寿命有关,而降低活性则与衰老相关疾病的发生有关。然而,Sirtuins 也可以发挥有害的细胞作用,其中增加的活性会导致病理生理学改变。因此,通过激活剂和抑制剂来调节 Sirtuin 的活性,对于确定 Sirtuins 在健康和疾病中的细胞作用以及开发治疗方法具有重要意义。本文不是全面综述,而是讨论了迄今为止已有的经过充分研究的 Sirtuin 激活剂和抑制剂,特别是那些具有已证明的选择性、效力和细胞活性的激活剂和抑制剂。本文还就 Sirtuin 调节剂的发现和改进的发展,针对实用研究,提供了最佳 Sirtuin 激活剂和抑制剂的建议。